Hana Solution LLC – Insights
Turkish Cosmetics Manufacturer FDA Registration: Buyer Verification Checklist
Turkish cosmetics manufacturer FDA registration is not a one-time filing — it lapses without a biennial renewal, and a lapsed registration can hold a shipment at the border even when the product itself is fully compliant. Buyers who verify facility registration, US Agent designation, and FEI number before commercial engagement avoid discovering a compliance gap after goods are already in transit.
Turkish Cosmetics Manufacturer FDA Registration: What US Buyers Must Verify Before Commercial Commitment
Many US buyers assume that an FDA-registered Turkish cosmetics manufacturer is automatically compliant. That assumption is usually wrong. Turkish cosmetics manufacturer FDA registration is not one fact you can take at a supplier's word — it is at least four separate, independently verifiable filings, and getting any one of them wrong can mean a shipment detained at the US port of entry.
The scale involved is real: since MoCRA (the Modernization of Cosmetics Regulation Act of 2022) took effect, FDA has registered 15,309 unique, active cosmetic product facilities and 1,102,092 unique, active product listings worldwide as of March 31, 2026 (FDA.gov, Registration & Listing of Cosmetic Product Facilities and Products). What that scale doesn't show buyers is how many of those registrations are current, correctly attributed, or actually tied to the specific cosmetics supplier in Turkey quoting their order. The recurring buyer-side mistake is treating "FDA registration" as a yes/no compliance checkbox — when it is in fact a set of distinct filings (facility registration, product listing, Responsible Person designation, US Agent appointment) that can each be true, false, lapsed, or misattributed independently of one another, on the same supplier, at the same time.
FDA registration is not a certificate and not an approval — it is a set of filings a buyer can verify independently, line by line, before commercial commitment.
Why This Matters Now
During cosmetics and personal-care sourcing engagements from Turkey, the most consistently observed gap has not been outright fraud — it has been suppliers and buyers alike conflating registration status with product approval, or assuming a registration completed in 2024 is still active without checking the renewal date. FDA itself flags this directly: cosmetic product facility registration and product listing is "neither a cosmetic approval program nor a promotional tool," and FDA "does not issue certificates" for either (FDA.gov). On February 11, 2026, FDA updated its Cosmetics Direct portal to add REGISTRATION STATUS and RENEWAL DATE fields precisely because so many facilities were losing track of their own biennial renewal deadlines (FDA.gov, Feb 2026). If FDA is building tooling to help registered facilities track their own status, buyers relying on a supplier's verbal assurance are working with less visibility than the facility itself.
MoCRA in Practice: What a Turkish Manufacturer Is Actually Required to File
MoCRA — Public Law 117-328, signed December 29, 2022 — is the most significant expansion of FDA's cosmetics authority since the original Federal Food, Drug, and Cosmetic Act of 1938 (Congressional Research Service, R47826). For a Turkish manufacturer producing cosmetic products for the US market, it creates two separate filing obligations that sit with two potentially different parties.
- Facility registration (Form FDA 5066). Any facility that manufactures or processes cosmetic products distributed in the US must register with FDA, using an FDA Establishment Identifier (FEI) number obtained in advance. This obligation sits with the manufacturing facility itself — the Turkish plant — regardless of who owns the brand.
- Product listing (Form FDA 5067). Each marketed cosmetic product must be listed with FDA, including ingredients, with updates required annually. This obligation sits with the Responsible Person — the manufacturer, packer, or distributor whose name appears on the product label — which is not always the manufacturing facility (FDA.gov).
This split is where most buyer confusion starts: a Turkish facility can be correctly registered while the product itself is unlisted, because listing is the Responsible Person's obligation — and on a private-label order, the Responsible Person is frequently the US buyer's own brand, not the Turkish manufacturer.
Turkish Manufacturers Aren't Starting From Zero — MoCRA Next to the Framework They Already Run
This is the piece most US-focused guidance skips, and it matters directly to buyers: a Turkish cosmetics manufacturer exporting to the EU is very likely already operating under Turkey's own Kozmetik Ürünler Yönetmeliği, published by TİTCK (Türkiye İlaç ve Tıbbi Cihaz Kurumu — the Turkish Medicines and Medical Devices Agency) in Official Gazette No. 32184 on May 8, 2023, and explicitly harmonized with EU Regulation 1223/2009 under the Turkey–EU Association Council Decision 1/95 (TİTCK, cosmetics regulation). That EU-aligned baseline is a genuine advantage — a facility already producing a Product Information File and safety assessment for EU export is not starting from a blank page for MoCRA — but it is not a substitute for MoCRA, and the two frameworks diverge in specific, consequential ways.
| Turkey / EU Framework (TİTCK, Reg. 1223/2009) | MoCRA (US) | |
|---|---|---|
| Responsible Person location | Must be established within the EU (or Turkey, for the Turkish market) — a facility-adjacent requirement | No EU/Turkey-style location requirement — can be the Turkish manufacturer itself, if named on the label |
| Core dossier | Product Information File (PIF) plus a Safety Assessment Report prepared by a qualified Responsible Technical Person | Safety substantiation maintained by the Responsible Person — no PIF-equivalent structured dossier format is mandated |
| Notification | CPNP-style product notification before EU market placement | Product listing via Form FDA 5067, annually updated |
| Facility-level filing | No separate biennial facility registration requirement under the EU/Turkey model | Facility registration (Form FDA 5066) required, renewed every two years on a per-facility anniversary date |
| Export support document | Certificate of Free Sale available from Turkish authorities to support export market entry | Not an FDA filing requirement itself, but frequently requested by US importers as commercial due-diligence evidence |
The practical takeaway for buyers: a Turkish manufacturer's EU compliance maturity is a reasonable positive signal — it suggests an organization that already handles a Responsible Person structure and formal safety documentation — but it answers a different question than "is this facility MoCRA-registered." The two have to be verified separately, on their own terms.
Responsible Person vs. US Agent — Two Different Roles, Often Confused
These two roles are frequently used interchangeably in supplier communication. They are not the same obligation, they are not held by the same party, and confirming one does not confirm the other.
| Responsible Person | US Agent | |
|---|---|---|
| Who it is | The manufacturer, packer, or distributor whose name appears on the product label (per FD&C Act §609(a) / Fair Packaging and Labeling Act §4(a)) | A US-located point of contact a foreign facility must appoint as part of facility registration |
| Location requirement | No requirement to be US-based — can be the Turkish manufacturer itself, if its name is on the label | Must be located in the United States |
| Core obligation | Bears legal responsibility for product safety substantiation and files the annual product listing (Form 5067) | Serves as FDA's point of contact for the foreign facility — does not hold product or brand rights |
| On a private-label order | Frequently the US buyer's own brand, once its name is on the label — not automatically the Turkish factory | Required specifically because the manufacturing facility is foreign — separate from the Responsible Person question entirely |
| Confirming this role verifies | Who is legally accountable for the product's safety file and listing | Whether the manufacturing facility has satisfied its own registration prerequisite — not who owns the product |
A supplier confirming "we have a US Agent" answers a facility-level question. It says nothing about whether the product itself is listed, or who is legally the Responsible Person for that listing. Buyers who stop at the US Agent confirmation have verified one of at least four required data points.
Registration Is Not a One-Time Event — Renewal Runs on a Per-Facility Clock
Facility registration must be renewed every two years, and the renewal date is not a fixed industry-wide deadline — it runs from each facility's own initial registration date. FDA's own guidance is explicit: "if FDA received your initial registration on February 20, 2024, then your renewal date would be by February 20, 2026" (FDA.gov). This means two Turkish facilities that both registered "in 2024" can have renewal deadlines months apart, and a registration confirmed as active in one quotation cycle can lapse by the next one — a supplier's registration screenshot from six months ago proves nothing about status today.
A facility registration confirmed active in Q1 does not confirm status in Q3. Renewal runs on that facility's own anniversary date — ask for the specific renewal date, not a general "we're FDA registered" statement.
A Worked Example: One Private-Label Serum Order, Four Separate Checks
Take a US indie skincare brand sourcing a private-label facial serum from a Turkish contract manufacturer, to be sold under the brand's own label in the US.
Check 1 — Facility registration
The Turkish manufacturing facility itself must hold an active Form FDA 5066 registration with a valid FEI number. This is the factory's obligation, independent of the brand relationship.
Check 2 — Responsible Person
Because the US brand's name is on the label, the US brand — not the Turkish factory — is very likely the Responsible Person, and carries the legal obligation for safety substantiation and product listing. A Turkish manufacturer claiming "we handle FDA compliance for you" may be describing support with documentation, not a transfer of legal responsibility that MoCRA does not allow to shift by contract alone.
Check 3 — US Agent
Separately from the label question, the Turkish facility must have a US Agent on file as part of its own registration — a US-located contact FDA can reach directly.
Check 4 — Product listing
The specific serum formulation must be listed via Form FDA 5067, with ingredients disclosed, before or as required alongside commercial marketing — and updated annually.
Four checks, two different responsible parties, one shipment. A buyer who confirms only that "the factory is FDA registered" has verified Check 1 and possibly Check 3 — and has not verified whether the product they are actually importing is listed, or who legally owns the safety substantiation file for it.
Illustrative example only. Actual Responsible Person attribution depends on label content and the specific commercial arrangement — confirm directly against FDA's Responsible Person definition for each order.
Buyer Verification Checklist — Before Commercial Commitment
These six items should be confirmed independently, in writing, before a Turkish cosmetics manufacturer is treated as compliance-ready for a US-bound order:
| Item | What to confirm |
|---|---|
| Facility Registration | Active Form FDA 5066 registration exists for the specific manufacturing facility — not a group entity or affiliated facility |
| Renewal Status | The facility's specific renewal date (anniversary-based, not calendar-fixed) has not lapsed |
| FEI Number | The FDA Establishment Identifier matches the facility named in the registration — verifiable via FDA's FEI Search Portal |
| US Agent | A US-located US Agent is on file for the facility, as required for foreign-facility registration |
| Product Listing | The specific product formulation is listed under Form FDA 5067, with the correct Responsible Person attributed — updated within the required annual cycle |
| Documentation Scope Match | ISO 22716 (cosmetics GMP) certification, if held, covers the specific product category being ordered — not a different product line at the same facility |
Registration and listing status can be independently checked against FDA's public tools rather than accepted on a supplier's representation alone — this is a verification step, not a formality.
Where This Intersects With Supplier Verification
FDA registration status is a distinct question from manufacturer legitimacy, but the two are frequently bundled into a single assumption by buyers new to Turkey-origin cosmetics sourcing.
A facility with an active FDA registration and US Agent on file is not automatically the entity described in a supplier's sales deck — confirming manufacturer status, export history, and facility identity is a separate step, the focus of supplier verification and risk screening. Conversely, a manufacturer with strong production credentials and ISO 22716 certification is not automatically FDA-compliant for the specific product being quoted — regulatory filing status has to be checked on its own terms. This is also where trader-versus-manufacturer confusion compounds the risk: a trading intermediary presenting as a contract manufacturer may quote a registered facility's FEI number while having no direct relationship to the product actually shipped. Buyers who have already confirmed manufacturer identity still need registration, listing, and Responsible Person attribution checked as a distinct, additional step during RFQ governance — before the order is placed, not after the shipment is refused entry. The full compliance and certification map for this category — GMP scope, REACH, EU Responsible Person, and MoCRA side by side — is maintained on Hana Solution's cosmetics sourcing page.
Frequently Asked Questions
Yes. Under MoCRA, any facility that manufactures or processes cosmetic products distributed in the United States must register with FDA using Form FDA 5066, regardless of the facility's country of location, and renew that registration every two years.
A US Agent is a US-located contact a foreign facility must appoint as part of its own facility registration — it does not hold product or brand rights. A Responsible Person is the manufacturer, packer, or distributor whose name is on the product label, and carries legal responsibility for safety substantiation and product listing. They are frequently different parties on the same order.
No. FDA states directly that cosmetic product facility registration and product listing is neither a cosmetic approval program nor a promotional tool, and that FDA does not issue certificates for either. A supplier describing itself as "FDA approved" or "FDA certified" for cosmetics is using terminology FDA itself does not apply to this filing.
Every two years, on a per-facility basis — the renewal date is calculated from that facility's own initial registration date, not a fixed calendar date shared across the industry. A registration confirmed active at one point in the year is not automatically still active later.
A lapsed or suspended facility registration puts products from that facility at risk of being refused entry at the US port of import. FDA also has separate authority to suspend a facility's registration where a product from that facility poses a serious health risk — in either case, the buyer bears the commercial consequence of a shipment that cannot clear.
MoCRA includes a small-business exemption from facility registration and product listing tied to average gross cosmetic sales over the prior three years. However, this exemption does not apply to products that contact the eye's mucous membrane, are injected, are intended for internal use, or are intended to alter appearance for more than 24 hours — categories common in some personal-care lines. Exemption status should be confirmed for the specific product, not assumed from company size alone.
No. ISO 22716 is a cosmetics Good Manufacturing Practice standard addressing production quality systems. It is independent of, and does not substitute for, FDA facility registration (Form 5066) or product listing (Form 5067) — a facility can hold ISO 22716 certification and still have no active FDA registration, or the reverse.
No. Turkey's Kozmetik Ürünler Yönetmeliği, administered by TİTCK and harmonized with EU Regulation 1223/2009, is a separate legal framework from MoCRA — there is no mutual recognition between them. A facility with a strong EU compliance file (Product Information File, EU Responsible Person, CPNP notification) is not automatically FDA-registered; facility registration and product listing must still be completed independently for the US market.
No. Hana Solution does not perform FDA facility registrations or issue regulatory certifications. We verify whether Turkish manufacturers have completed the required registrations, documentation, and compliance steps before commercial commitment — the filings themselves remain the responsibility of the facility and the Responsible Person, made directly with FDA or through qualified regulatory counsel.
Before You Commit to a Turkish Cosmetics Manufacturer
Compliance assumptions built before these points are confirmed in writing are, in most cases, incomplete:
- Active Form FDA 5066 facility registration — for the specific manufacturing facility, not an affiliated entity
- Current renewal date confirmed — anniversary-based, not assumed from a prior conversation
- US Agent on file for the facility, separate from any Responsible Person question
- Product listing (Form FDA 5067) filed for the specific formulation, with correct Responsible Person attribution
- ISO 22716 or other GMP documentation scope-matched to the actual product category ordered
If you need an independent buyer-side assessment before commercial commitment, Hana Solution supports sourcing direction, supplier verification, and RFQ governance for buyers evaluating a cosmetics supplier in Turkey — without trading, commission, or supplier affiliation. Hana Solution LLC does not perform FDA facility registrations or issue regulatory certifications. We verify whether Turkish manufacturers have completed the required registrations, documentation, and compliance steps before commercial commitment.
Last reviewed: July 14, 2026
This Insight does not constitute regulatory, customs, or legal advice, and it does not substitute for direct confirmation with FDA or qualified regulatory counsel for a specific facility or product. Registration figures, exemption thresholds, and program details referenced here reflect publicly available FDA.gov guidance as of July 14, 2026, and are subject to change — always confirm current status directly against FDA's registration tools before commercial commitment.
Submit a project brief. We verify facility registration, product listing, and documentation status before your RFQ is issued — without trading, commission, or supplier affiliation.